How many studies have been conducted on Donepezil?

BiohacksAI has indexed 298 PubMed studies on Donepezil, including 45 randomized controlled trials (RCTs). 60% of studies involve human subjects.

What are the main research areas for Donepezil?

The primary research domains for Donepezil are 🧠 Neuroprotection, 🧠 Cognitive, 🧠 Memory. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Donepezil

An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.

298+ PubMed studies analyzed · 45 RCTs · Evidence Score: 53

Research Domains

Donepezil has been studied across 23 research domains including 🧠 Neuroprotection, 🧠 Cognitive, 🧠 Memory, 🧠 Learning, 🧠 Focus & Attention. The primary research focus is 🧠 Neuroprotection with 53% of studies addressing this area.

Loading evidence profile...

This evidence profile for Donepezil is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.